VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $630,000 | -13.8% | 4,400 | -21.0% | 0.24% | -31.8% |
| Q3 2014 | $731,000 | +4.1% | 5,570 | 0.0% | 0.35% | +12.8% |
| Q2 2014 | $702,000 | -4.4% | 5,570 | 0.0% | 0.31% | -24.1% |
| Q1 2014 | $734,000 | +12.2% | 5,570 | 0.0% | 0.41% | +12.9% |
| Q4 2013 | $654,000 | -10.0% | 5,570 | -20.1% | 0.36% | -16.5% |
| Q3 2013 | $727,000 | +4.3% | 6,970 | -14.0% | 0.44% | -12.1% |
| Q2 2013 | $697,000 | – | 8,100 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |